BC3 Technologies Accelerates Growth and Strengthens Maryland MedTech FootprintBaltimore-Based Medical Technology Company on Track for More Than 500% Revenue Growth While Expanding Jobs, Manufacturing, and Innovation in Maryland
Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray-- FDA-Cleared Aerosolized Chitosan Hemostatic Agent Receives Patent for its Innovative Material and Method --
